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Cleavage of the Notch receptor via a γ-secretase, results in the release of the active intra-
cellular domain of Notch that migrates to the nucleus and interacts with RBP-Jκ, resulting
in the activation of downstream target genes. This canonical Notch signaling pathway has
been documented to influence T cell development and function. However, the mechanis-
tic details underlying this process remain obscure. In addition to RBP-Jκ, the intra-cellular
domain of Notch also interacts with other proteins in the cytoplasm and nucleus, giving
rise to the possibility of an alternate, RBP-Jκ independent Notch pathway. However, the
contribution of such RBP-Jκ independent, “non-canonical” Notch signaling in regulating
peripheral T cell responses is unknown. In this report, we specifically demonstrate the
requirement of Notch1 for regulating signal strength and signaling events distal to the T
cell receptor in peripheral CD4+T cells. By using mice with a conditional deletion in Notch1
or RBP-Jκ, we show that Notch1 regulates activation and proliferation of CD4+T cells inde-
pendently of RBP-Jκ. Furthermore, differentiation toTH1 and iTreg lineages although Notch
dependent, is RBP-Jκ independent. Our striking observations demonstrate that many of
the cell-intrinsic functions of Notch occur independently of RBP-Jκ. Such non-canonical reg-
ulation of these processes likely occurs through NF-κ B.This reveals a previously unknown,
novel role of non-canonical Notch signaling in regulating peripheral T cell responses.
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INTRODUCTION
The Notch receptor protein plays a crucial role in embryonic
development and specification of cell fates (1). There are four
Notch receptors (Notch1–4), which can be activated by ligands
that belong to either the Delta-like (DLL1, 3, 4) or Jagged fam-
ily (Jagged 1 and 2) of proteins (2). Binding of a Notch ligand
to the receptor triggers a series of proteolytic cleavages that cul-
minate in the release of the intra-cellular domain of Notch by
γ-secretase. This active, intra-cellular fragment of Notch migrates
to the nucleus and interacts with the transcriptional repressor –
recombination signal – binding protein-Jκ (RBP-Jκ). Following
recruitment of co-activators such as p300 and master-mind-like
(MAML), RBP-Jκ is converted to a transcriptional activator lead-
ing to the expression of downstream target genes. Such RBP-Jκ
dependent or canonical Notch signaling has been long thought
to regulate T cell responses. Recent reports suggest that the intra-
cellular domain of Notch also interacts with other proteins besides
RBP-Jκ in the cytoplasm and nucleus suggesting that Notch could
possibly use an alternate route to exert some of its effects in an
RBP-Jκ – independent or“non-canonical”fashion (3–6). However,
whether or not such non-canonical Notch signaling is involved in
regulating peripheral T cell responses is unknown.
T cell receptor (TCR) mediated activation of peripheral T
cells is a fundamental process of the adaptive immune system.
Activation of CD4+ T cells is accomplished by binding of an
antigen to the TCR presented by an MHC Class II molecule
on the antigen-presenting cell. A co-stimulatory signal between
B7 (CD80/CD86) on the antigen-presenting cell and CD28 on
the T cell stimulates the onset of multiple downstream signal-
ing events, which result in T cell activation and proliferation.
Helper T cells can differentiate into at least four different lin-
eages (TH1, TH2, TH17, T-reg) depending on the cytokine milieu.
Interleukin-12 and IFN-γ polarize CD4+ T cells to the TH1 phe-
notype. TH1 cells express the lineage specific transcription factor
T-bet, secrete the signature cytokine IFN-γ, and provide protection
against intra-cellular pathogens (7). TH2 cells, which are induced
by IL-4, are primarily involved in asthma and allergies, and pro-
tect against extra-cellular parasites. They require the transcription
factor GATA3 to secrete IL-4, IL-5, and IL-13 (8). Interleukin-6
and TGF-β generate TH17 cells, which provide protection against
nematodes and fungal infections, secrete signature cytokines IL-17
and IL-23 and express ROR-γt (9–11). Induced regulatory T cells
(iTregs), which are also induced by TGF-β, are characterized by the
expression of FoxP3 and exhibit immuno-suppressive functions
(12–14).
Ligation of the TCR accompanied by co-stimulation, generates
intra-cellular Notch in CD4+ T cells while inhibition of Notch acti-
vation with γ-secretase inhibitors (GSI) decreases T cell activation
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as well as proliferation (15, 16). Since GSIs have multiple substrates
and inhibit all Notch receptors (17), whether such a decrease in
T cell activation is precisely due to Notch1, or a GSI induced
effect, is ambiguous and needs to be investigated. Additionally,
precisely the point in the TCR signaling cascade Notch at which
Notch is involved remains to be determined. Several studies using
various approaches to inhibit Notch activity have reported con-
flicting functions of Notch in regulating T cell activation as well
as differentiation. Notch signaling has been shown to regulate dif-
ferentiation to TH1, TH2, TH17, and iTreg lineages (4, 18–20).
Pharmacological inhibition of Notch using GSIs dampens the abil-
ity to adopt a TH1 fate by attenuating the expression of T-bet (4).
However, inhibition of signaling downstream of RBP-Jκ via genetic
deletion or by using dominant negative MAML inhibits adoption
of a TH2 fate in vivo while preserving a TH1 phenotype (21–23).
Given the ability of intra-cellular Notch to interact with proteins
different from RBP-Jκ, it is possible that disparate results could
be attributed to RBP-Jκ independent functions of Notch. Fur-
thermore, whether canonical and non-canonical Notch signaling
affects T cell activation and differentiation processes differently
requires further investigation.
In this study, we report that Notch is required for control-
ling signaling events distal to the T cell receptor and also acts
as a critical regulator of TCR signal strength. We also show that
activation and proliferation of peripheral CD4+ T cells specifi-
cally requires Notch1 but not RBP-Jκ since conditional deletion
of Notch1 impaired these processes while conditional deletion of
RBP-Jκ had no effect. Such non-canonical, RBP-Jκ independent
regulation of these processes likely occurs via NF-κB. Conditional
deletion of Notch1 also impaired polarization to TH1 and induc-
tion of regulatory T cells in vitro. Nevertheless, RBP-Jκ deficiency
did not impair TH1 or iTreg cell fate in vitro once again support-
ing a novel role of non-canonical Notch signaling in controlling
differentiation toward these lineages. In vitro polarization to TH2
was not affected in the absence of either Notch1 or RBP-Jκ. Our
in vitro observations demonstrate a cell-intrinsic function of RBP-
Jκ independent Notch signaling in regulating peripheral T cell
responses. Such non-canonical regulation of these processes may
serve to explain some of the differential, pleiotropic effects of
Notch.
RESULTS
Notch IS REQUIRED FOR DISTAL TCR SIGNALING EVENTS
Activation of T cells via the TCR accompanied by co-stimulation
leads to the production of the active, intra-cellular domain of
Notch1 (N1IC) and its inhibition via γ-secretase inhibitors (GSI),
decreases activation, and proliferation of T cells (15, 16). While
Notch has been demonstrated to influence T cell activation, pre-
cisely where Notch exerts its influence downstream of the TCR
is obscure. Furthermore, whether Notch affects signaling events
proximal or distal to the TCR is unclear. To address these questions,
we determined the kinetics of Notch activation over time and asked
how inhibition of Notch activation via GSI treatment influences
downstream TCR signaling events at early and late time points
after stimulation. We detected N1IC in CD4+ T cells activated
with plate-bound anti-CD3ε and anti-CD28 4 h after activation
and the amount of N1IC increased over time (Figure 1A). This
increase was abrogated after GSI treatment (Figure 1A). Inhibition
of Notch activation did not alter proximal signaling events as
evidenced by intact phosphorylation of Zap 70 even in GSI treated
cells (Figure 1B). On the contrary, GSI treatment significantly
decreased distal TCR signaling events such as the expression of
activation markers CD25, CD69, IL-2, and IFN-γ (Figures 1C–F).
This decrease was most prominent close to 48 h after TCR stimula-
tion suggesting that Notch activation is critical for signaling events
distal to the TCR, but could be dispensable for proximal events.
Since we observed that activating cells via the TCR also triggered
the activation of Notch, we determined whether CD4+ T cells
themselves express Notch ligands. We observed that surface expres-
sion of DLL1 and Jagged1 is minimal upto 6 h after activation
and peaks at distal time points (Figures S1A,B in Supplementary
Material). Based on this observation, we determined whether stim-
ulating T cells in the presence of recombinant Notch ligands alters
the generation of N1IC downstream of the TCR. Activation in the
presence of recombinant DLL1 or Jagged1 did not alter the gener-
ation of N1IC nor did it impact T cell activation (Figures S1C–H in
Supplementary Material). Finally, stimulating T cells via the TCR
in the presence of DLL1 or Jagged1 did not significantly influence
the acquisition of helper T cell fate, although DLL1 enhanced IFN-
γ production under pre-existing TH1 conditions (Figures S1I,K in
Supplementary Material). Collectively, these data show that N1IC
is generated in CD4+ T cells after stimulating via the TCR and
influences distal TCR signaling events.
Notch AS A REGULATOR OF SIGNAL STRENGTH
A possible role of Notch as a regulator of signal strength has been
observed in thymocytes since constitutive expression of N1IC in
DP thymocytes prevented their maturation into single positive
CD4+ and CD8+ T cells by interfering with TCR signal strength
(24). However, whether Notch can influence the strength of TCR
signaling in peripheral CD4+ T cells is unknown. Given the impor-
tance of Notch signaling in regulating activation, we asked whether
it also influenced the threshold of signaling via the TCR. Since lig-
ation of the TCR accompanied by co-stimulation was sufficient
for the expression of N1IC, we first determined if altering signal
strength could also influence the generation of N1IC. We stimu-
lated CD4+ T cells with increasing concentrations of anti-CD3ε
keeping the amount of anti-CD28 constant. Increasing signal
strength resulted in a corresponding increase in the amount of
N1IC expression (Figure 2A). This was also accompanied by an
increase in the percentage of cells expressing N1IC and this increase
could be inhibited by GSI treatment (Figure 2B). To determine
if Notch is required for regulating signal strength, we stimu-
lated cells with increasing amounts of anti-CD3ε after inhibiting
Notch activation via GSI treatment. While DMSO treated cells
secreted higher levels of IL-2 with increasing signal strength, GSI
treated cells secreted significantly low amounts of IL-2 even at the
highest signal strength of 10µg/ml anti-CD3ε (Figure 2C) sug-
gesting that Notch influenced the threshold of signaling via the
TCR. To confirm this observation, we stimulated D0.11.10-TCR
transgenic CD4+ T cells with antigen-presenting cells pulsed with
increasing concentrations of ova-peptide. Once again, increasing
antigen concentrations lead to a dose-dependent increase in the
amount of N1IC as well as the percentage of N1IC positive cells
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FIGURE 1 | Notch is required for distalTCR signaling events. Splenocytes
from C57BL/6J mice were pretreated with DMSO or GSI and stimulated with
plate-bound anti-CD3ε and anti-CD28 for the indicated times. Cells were
harvested and analyzed by flow cytometry after gating on CD4+ T cells. Mean
fluorescent intensity (MFI) values were plotted for (A) N1IC, (C) CD25, and
(D) CD69. (E) IL-2 and (F) IFN-γ ELISA from supernatants of cells stimulated
as described. (B) Western Blot for phosphorylated and Total Zap70.
Splenocytes from C57BL/6J mice were pretreated with DMSO or GSI and
stimulated with anti-CD3ε and anti-CD28 for the indicated time points. Whole
cell lysates were made at for each time point and analyzed by Western
Blotting. Data are representative of three independent experiments. Data
represent the mean±SEM n=3. *p<0.05, **p< 0.005, and ***p<0.001.
(Figures 2D,E). This increase could be blocked after GSI treatment
(Figure 2E). In addition to N1IC, increasing signal strength also
led to an increase in IL-2. However in the absence of Notch activa-
tion, even high concentrations of ova-peptide were not sufficient
for maximal IL-2 production (Figure 2F). These data demon-
strate that not only can the levels of N1IC be influenced by the
amount of signal via the TCR, but also Notch itself can regu-
late signal strength by decreasing the threshold of signaling. In
addition to Notch, the cell cycle regulator c-Myc is also influ-
enced by TCR signal strength as strong peptide agonists cause a
greater induction and nuclear translocation of c-Myc in T cells
(25). c-Myc is a downstream target of Notch and is suspected to
be important in thymocyte development and T cell function (25–
28). Thus, we asked whether or not the regulation of c-Myc in
response to signal strength was Notch dependent. We first con-
firmed Notch dependency of c-Myc in T cells. In concurrence
with previous reports, we observed that phosphorylated and total
c-Myc had a biphasic appearance in T cells and peaked at 4 and 24 h
after TCR stimulation (28). However in addition to these results,
we also observed that inhibition of Notch activation abrogated
both phosphorylated and total c-Myc with the most prominent
reduction at 48 h post stimulation (Figures 2G,H). Additionally,
increasing signal strength lead to an increase in the expression of
c-Myc, which was abrogated in the absence of Notch activation
(Figure 2I). Thus, these data show that Notch is required for sus-
tained c-Myc induction in peripheral CD4+ T cells. Furthermore,
the induction of c-Myc in response to signal strength is Notch
dependent.
Notch1 IS REQUIRED FOR ACTIVATION AND PROLIFERATION OF CD4+
T CELLS
Inhibition of Notch activation using GSIs has been demonstrated
to abrogate activation and proliferation of CD4+ T cells (15, 16).
However, GSIs inhibit all isoforms of Notch and have multiple
substrates (17). Hence, the specific role of Notch1 in control-
ling these processes requires further investigation. To determine
the specific function of Notch1 in T cell activation and differ-
entiation, we conditionally knocked-out Notch1 in peripheral T
cells by crossing mice with loxp-flanked Notch1 alleles, to mice
expressing Cre recombinase under the control of the interferon
responsive Mx promoter (29). The Mx Cre promoter enables
acute deletion of Notch1 in peripheral T cells. Since Notch1 is
required for development of T cells (30–32), this deletion strat-
egy enables cells to develop normally in the presence of Notch,
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FIGURE 2 | Notch as a regulator of signal strength. (A) Histogram for
N1IC expressed in CD4+ T cells stimulated with the indicated
concentrations of anti-CD3ε and 1µg/ml of anti-CD28 for 48 h. Data
represent three independent experiments. (B,C) CD4+ T cells were
pretreated with DMSO or GSI and activated with the indicated
concentrations of anti-CD3ε and 1µg/ml of anti-CD28 for 48 h.
(B) Percentage of cells expressing N1IC as determined by flow cytometry.
(C) IL-2 ELISA from supernatants n=3–5. (D–F) CD4+ T cells were isolated
from DO.11.10 – TCR transgenic mice and pretreated with DMSO or GSI
prior to co-culture with CHO-APCs expressing MHC-II and B7. They were
pulsed with the indicated concentrations of ova-peptide 323–339. Cells
were harvested after 48 h and analyzed by flow cytometry after gating on
D0.11.10 TCR positive CD4+ T cells. (D) Histogram for N1IC expressed in
CD4+ T cells expressing the D0.11.10 TCR stimulated with the indicated
concentrations of ova-peptide. Data represent three independent
experiments. (E) Percentage of cells expressing N1IC as determined by
flow cytometry n=3. (F) IL-2 ELISA from supernatants n=3. (G) Western
Blot for phosphorylated and total c-Myc. Splenocytes from C57BL/6J mice
were pretreated with DMSO or GSI and stimulated with plate-bound
anti-CD3ε and anti-CD28 for the indicated times. Whole cell lysates were
made at each time and analyzed by Western Blotting. Data represent three
independent experiments. (H) Integrated density values obtained after
normalizing phospho and total c-Myc to Actin. (I) Western Blot for c-Myc
expressed in CD4+ T cells stimulated as described in (A). Data represent
three independent experiments. Data represent the mean±SEM,
*p<0.05, **p<0.005, ***p< 0.001.
before its deletion in the periphery. Both Notch1fl/fl Mx Cre±
mice (abbreviated as cN1KO) and Notch1fl/fl Mx Cre−/− mice
(abbreviated as control) were injected with equivalent amounts
of Poly I:Poly C and rested for 3 weeks before use (29). CD4+ T
cells from cN1KO animals showed a significant decrease in Notch1
transcript as well as a marked reduction in the amount of N1IC
expression (Figures S2A,D in Supplementary Material) (29). We
also confirmed the expression of other Notch receptors in CD4+
T cells from control and cN1KO animals and observed an increase
in the expression of Notch2 and Notch3 transcripts in the absence
of Notch1 (Figures S2B,C in Supplementary Material). We could
not detect Notch4 in cells from either control or cN1KO mice.
In addition, both cN1KO and control mice expressed similar per-
centages of CD4+ and CD8+ peripheral T cells (Figures S2E,F in
Supplementary Material). To investigate the specific contribution
of Notch1 in influencing activation of peripheral T cells, CD4+ T
cells from cN1KO or control animals were stimulated in vitro with
anti-CD3ε and anti-CD28 and activation markers were observed
by flow cytometry. cN1KO animals had a significantly lower per-
centage as well as absolute number of cells expressing CD25 and
CD69 (Figures 3A,B,D,E). Since cN1KO mice were knocked-down
for Notch1, as an internal control we gated on the small percentage
of residual Notch1 positive cells in the cN1KO animals. These cells
continued to express high levels of CD25 and CD69. However,
cells deficient for Notch1 expressed lower levels of both activa-
tion markers (Figures 3C,F). This decrease was accompanied by a
significant reduction in the levels of IL-2 and IFN-γ secreted post-
activation (Figures 3G,H). Whether CD4+ T cells from cN1KO
animals were also impaired in their ability to proliferate was
determined by measuring the incorporation of 3H-thymidine.
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FIGURE 3 | Notch1 is required for activation and proliferation of CD4+ T
cells. CD4+ T cells were isolated from Control or cN1KO mice and stimulated
with plate-bound anti-CD3ε and anti-CD28. Cells were harvested after 48 h
(A–F,J) or at indicated times (G–I). Cells were surface stained for CD4, CD25,
and CD69 and intra-cellular stained for N1IC and analyzed by flow cytometry.
(A,D) Dot plots obtained after flow cytometry. Data are representative of four
independent experiments. Numbers in each quadrant represent percentage
of cells. (B) Percentage of cells and cell counts for cells positive for CD25 and
(E) CD69. (A,D) n=4. (C,F) Histograms for CD25 and CD69 after gating on
Notch negative cells from cN1KO mice (dashed line), Notch positive cells
from cN1KO mice (dotted line), or CD4+ T cells from Control mice (solid line).
Data represent four independent experiments. (G) IL-2 and (H) IFN-γ ELISA
from supernatants obtained from control and cN1KO mice stimulated as
described above n=4. (I) Counts per minute (CPM) obtained after
3H-thymidine uptake in CD4+ T cells from control and cN1KO mice stimulated
as described above with and without rmIL-2 (20 ng/ml). Data represent three
independent experiments. (J) IL-2 ELISA from supernatants of CD4+ T cells
from Control or cN1KO mice stimulated with the indicated concentrations of
anti-CD3ε and 1µg/ml of anti-CD28 for 48 h n=3–5. Data represent
mean±SEM. *p<0.05, **p<0.005.
Proliferative capability was significantly diminished in the absence
of Notch1 and could not be rescued by adding exogenous IL-2
(Figure 3I). To determine if the observed decrease in proliferation
was due to enhanced apoptosis in the absence of Notch1, Annexin
V positive cells from control or cN1KO animals were analyzed
by flow cytometry. CD4+ T cells from cN1KO animals had only
marginally more apoptosis 48 h after activation (Figures S3A,B in
Supplementary Material). Since Notch1 was required for the acti-
vation and proliferation of CD4+ T cells, we asked whether it
also influenced the threshold of signaling via the TCR. CD4+ cells
from control and cN1KO animals were stimulated with increas-
ing concentrations of anti-CD3ε accompanied by co-stimulation.
While cells from control mice secreted higher levels of IL-2 with
increasing signal strength, cells from cN1KO mice had low levels
of IL-2 even at the highest signal strength of 0.2µg/ml anti-
CD3ε (Figure 3J). These results demonstrate that activation and
proliferation of CD4+ T cells specifically requires Notch1. Further-
more, Notch1 also acts to decrease the threshold for signaling via
the TCR.
Notch1 IS REQUIRED FOR TH1 DIFFERENTIATION AND PRODUCTION OF
iTregs IN VITRO
Although Notch has been implicated in influencing differentia-
tion of T cells, the precise role of Notch1 in favoring TH1 ver-
sus TH2 lineage decisions is unclear. While some studies have
shown that inhibiting Notch using GSIs diminishes the ability
of CD4+ T cells to adopt a TH1 fate, other studies using dif-
ferent strategies to inhibit Notch signaling have reported con-
flicting observations (21, 22, 33). To determine the precise role
of Notch1 in helper T cell differentiation, CD4+ T cells from
control or cN1KO mice were polarized in vitro to TH1, TH2, or
iTreg lineages. Absence of Notch1 impaired TH1 differentiation
in vitro. CD4+ T cells from cN1KO mice had significantly fewer
cells that stained positive for intra-cellular IFN-γ (Figures 4A,B).
Secreted IFN-γ was also reduced significantly in the absence
of Notch1 (Figure 4C). This decrease was accompanied by a
reduction in the amount of the master TH1 transcription fac-
tor T-bet (Figures 4D–F). In contrast, no marked effect was
observed in TH2 differentiation. Although, the amount of GATA3
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FIGURE 4 | Notch1 is required forTH1 differentiation and production of
iTregs in vitro. CD4+ T cells from control and cN1KO mice were differentiated
under TH1, TH2, or iTreg inducing conditions for 3 days followed by
re-stimulation with plate-bound anti-CD3ε. Cells were analyzed by flow
cytometry. Supernatants were used for ELISA. (A) Dot plots obtained from
flow cytometry showing intra-cellular staining for IFN-γ and IL-4. Numbers in
each quadrant represent percentage of cells. Data represent three to five
independent experiments. (B) Percentage and absolute cell numbers of IFN-γ
or IL-4 positive cells determined by flow cytometry n=3–5. (C) IFN-γ and IL-4
production under TH1 and TH2 conditions, respectively, determined by an
ELISA. Each data point represents one animal. (D,G) Dot plots showing
intra-cellular staining for (D) T-bet and N1IC under TH1 conditions (G) or GATA3
and N1IC under TH2 conditions. Numbers in each quadrant represent
percentage of cells. Data represent three to five independent experiments.
(E,H) Percentage and absolute numbers of double positive cells as
determined by flow cytometry n=3–5. (F) Histograms for T-bet and (I) GATA3
expression under TH1 and TH2 conditions, respectively. Data represent three
to five independent experiments. (J) Dot plots for CD25+ and FoxP3+ cells.
Numbers in each quadrant represent percentage of cells. Data represent
three independent experiments. (K) Percentage and absolute cell numbers of
double positive cells determined by flow cytometry n=3. Data represent
mean±SEM. *p<0.05, **p<0.005, and ***p<0.001. ns, not significant.
was reduced in the absence of Notch1 (Figures 4G–I), both con-
trol as well as cN1KO mice had similar percentages and absolute
number of CD4+ T cells that were positive for intra-cellular IL-4
(Figures 4A,B) and expressed comparable levels of secreted IL-4
(Figure 4C). Whether CD4+ T cells from cN1KO mice proliferated
differently under different polarizing conditions, was determined
by 3H-thymidine uptake under non-polarized (NP), TH1 and
TH2 conditions. Proliferative capability of CD4+ T cells from
cN1KO mice was the same under different polarizing conditions
(Figure S3C in Supplementary Material), despite of differences
in cytokine secretion. In addition to TH1, Notch1 deficiency sig-
nificantly reduced induced T-reg populations as observed by a
significant decrease in the frequency of CD25+FoxP3+ cells in
cN1KO animals (Figures 4J,K). These results show that Notch1
is required for TH1 and iTreg differentiation but is dispensable
for TH2 cell fate acquisition in vitro. Furthermore, these data
demonstrate an intrinsic role of Notch1 in regulating helper T
cell differentiation.
CANONICAL Notch SIGNALING IS NOT REQUIRED FOR ACTIVATION
AND PROLIFERATION OF CD4+ T CELLS
Several studies have highlighted an emerging role of non-canonical
Notch signaling in controlling helper T cell differentiation (5, 34).
This is potentiated by interactions of the intra-cellular domain of
Notch with other proteins besides RBP-Jκ in the cytoplasm and
nucleus. Some of these alternate binding partners include (but
are not limited to) NF-κB, T-bet, GATA3, PI3K, and Akt (3–5, 15,
21–23, 35). However, whether canonical and non-canonical Notch
signaling differs in their ability to influence T cell activation and
differentiation is not well defined. Hence, to determine the impor-
tance of RBP-Jκ-dependent, canonical Notch signaling, we condi-
tionally knocked-out RBP-Jκ in peripheral T cells by breeding mice
carrying RBP-Jκ loxp-flanked sites to mice expressing Cre recom-
binase under the control of the Mx promoter. CD4+ T cells from
RBP-Jκfl/fl Mx Cre± mice (abbreviated as cRBP-Jκ-KO) expressed
substantially reduced transcript and protein levels of RBP-Jκ in
comparison to to CD4+ T cells from RBP-Jκfl/fl Mx Cre−/−
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FIGURE 5 | Canonical Notch signaling is not required for activation and
proliferation of CD4+ T cells. CD4+ T cells were isolated from control or
cRBP-Jκ-KO mice and stimulated with plate-bound anti-CD3ε and
anti-CD28. Cells were harvested after 48 h (A–I) or at indicated times.
(J–L) Cells were surface stained for CD4, CD25, CD69, and intra-cellular
stained for N1IC and analyzed by flow cytometry. (A,D,G) Dot plots obtained
from flow cytometry showing CD4+ T cells positive for (A) N1IC, (D) CD25,
and (G) CD69. Numbers in each quadrant represent percentage of cells.
Data represent three independent experiments. (B,E,H) Percentage and
absolute numbers of cells positive for (B) N1IC, (E) CD25, and (H) CD69
obtained from dot plots n=4. (C,F,I) Histograms for (C) N1IC, (F) CD25, and
(I) CD69. Data represent three independent experiments. (J) Counts per
minute (CPM) obtained after 3H-thymidine uptake in CD4+ T cells from
control and cRBP-Jκ-KO mice stimulated as described above with and
without rmIL-2 (20 ng/ml). Data represent three independent experiments.
(K) IL-2 and (L) IFN-γ ELISA from supernatants obtained from control and
cRBP-Jκ-KO mice stimulated as described above n=6. Data represent
mean±SEM, ns, not significant.
mice (abbreviated as controls) (Figures S4A,B in Supplementary
Material). Additionally, cRBP-Jκ-KO mice had significantly fewer
peripheral CD4+ and CD8+ T cells in their spleens (Figures S4C,D
in Supplementary Material). To determine how canonical Notch
signaling influenced activation, CD4+ T cells from control and
cRBP-Jκ-KO mice were stimulated in vitro with anti-CD3ε and
anti-CD28. Absence of RBP-Jκ did not alter the production of
intra-cellular Notch1 after TCR stimulation (Figures 5A–C). In
contrast to impaired activation observed in the absence of Notch1
(Figure 3), RBP-Jκ deficiency did not alter the activation of CD4+
T cells. On the contrary, CD4+ T cells from cRBP-Jκ-KO animals
produced marginally higher numbers of CD4+ T cells express-
ing activation the markers CD25 and CD69 and displayed slightly
elevated amounts of each marker (Figures 5D–I). CD4+ T cells
from both cRBP-Jκ-KO mice secreted IL-2 and IFN-γ just as effi-
ciently as Controls (Figures 5K,L). Proliferation of CD4+ T cells
was unaffected by the absence of RBP-Jκ irrespective of addition of
recombinant IL-2 (Figure 5J). These results suggest that activation
and proliferation of CD4+ T cells is not impaired in the absence
of RBP-Jκ. However, since these processes required Notch1, our
data show that activation and proliferation occurs independently
of canonical Notch signaling.
ACTIVATION AND PROLIFERATION OF CD4+ T CELLS IS
RBP-Jκ-INDEPENDENT BUT Notch AND NF-κB DEPENDENT
To confirm that RBP-Jκ-independent activation and proliferation
was in fact Notch dependent but RBP-Jκ-independent, we used
the following strategies. We first inhibited activation of Notch in
CD4+ T cells from cRBP-Jκ-KO by treating these cells with GSI. To
control for the off-target effects of GSIs, we also treated cells with
a Notch sparing GSI (NS-GSI) that inhibited all GSI substrates
except Notch. GSI treatment of CD4+ T cells from cRBP-Jκ-KO
mice inhibited intra-cellular Notch (Figure 6A) and significantly
reduced the expression of the activation markers CD25 and CD69
(Figures 6B,C). This was accompanied by a significant decrease in
the cytokines IL-2 and IFN-γ (Figures 6D,E). Importantly,NS-GSI
treatment rescued Notch activation as well as CD25, CD69, and
IL-2 (Figures 6A–D). A partial rescue was observed with IFN-γ
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FIGURE 6 | Activation and Proliferation of CD4+ T cells is RBP-Jκ
independent but Notch and NF-κB dependent. CD4+ T cells were isolated
from cRBP-Jκ-KO mice, pretreated with DMSO, GSI, or NS-GSI (A–E,L,M) or
DHMEQ (F–J) and stimulated with plate-bound anti-CD3ε and anti-CD28 for
24 h. Cells were surface stained for CD4, CD25, and CD69 and intra-cellular
stained for N1IC and analyzed by flow cytometry. Supernatants were used to
detect IL-2 and IFN-γ by an ELISA mean fluorescent intensity (MFI) values
were plotted for (A,F) N1IC, (B,G) CD25, (C,H) CD69 n=3–5. Histograms to
the right of (A–C) show expression of N1IC, CD25, and CD69. Data represent
three independent experiments. (D,I) IL-2 and (E,J) IFN-γ as determined by an
ELISA. (K) Counts per minute (CPM) obtained after 3H-thymidine uptake in
CD4+ T cells from cRBP-Jκ-KO mice treated with DMSO or DHMEQ and
stimulated for 48 h. (L,M) Histograms representing a CFSE Proliferation
Assay. CD4+ T cells from cRBP-Jκ-KO mice pretreated with DMSO, GSI, or
NS-GSI were labeled with CFSE and activated with plate-bound anti-CD3ε and
anti-CD28 for 48 h followed by flow cytometry analysis. Data represent three
independent experiments. (M) Bar graph showing the percentage of CFSE
negative cells obtained by flow cytometry. Data represent three independent
experiments. Data represent mean±SEM. *p<0.05, **p<0.005, and
***p<0.001. ns, not significant.
(Figure 6E). Furthermore, a decrease in proliferation of CD4+
T cells from cRBP-Jκ-KO mice after GSI treatment was also res-
cued by the NS-GSI (Figures 6L,M). These data suggest that while
canonical Notch signaling is dispensable for the activation and
proliferation of peripheral CD4+ T cells, these processes require
intra-cellular Notch. The role of Notch and NF-κB in regulat-
ing T cell activation and differentiation processes has been well
documented (3, 15, 36, 37). We have shown that the intra-cellular
domain of Notch1 binds to and exerts some of its effects via NF-κB
suggestive of cross talk between the two pathways (3, 15). Hence,
we asked whether these RBP-Jκ-independent processes, were also
dependent on NF-κB. This was determined by examining acti-
vation markers after inhibiting NF-κB in CD4+ T cells lacking
RBP-Jκ using a pharmacological inhibitor, dehydroxymethyle-
poxyquinomicin (DHMEQ) (38). DHMEQ has been used to block
NF-κB activity in different types of solid tumors, malignant cells,
and T cells (39, 40). DHMEQ treatment effectively inhibited
nuclear translocation of NF-κB (Figures S6A,B in Supplementary
Material). Although DHMEQ treatment did not alter the levels of
N1IC (Figure 6F), DHMEQ treated CD4+ T cells from cRBP-Jκ-
KO mice showed a significant reduction in the amounts of CD25,
CD69, IL-2, and IFN-γ (Figures 6G–J). Furthermore, DHMEQ
treatment of CD4+ T cells from cRBP-Jκ-KO animals significantly
impaired proliferation (Figure 6K). These data show that activa-
tion and proliferation of CD4+ T cells is an RBP-Jκ-independent
but Notch dependent process. Furthermore, our data suggest that
non-canonical Notch signaling may control these processes, at
least in part through NF-κB.
RBP-Jκ-DEFICIENCY DOES NOT ALTER CD4+ T CELL DIFFERENTIATION
IN VITRO
Deletion of either Notch1 or RBP-Jκ has been shown to have dif-
ferent outcomes on helper T cell differentiation, suggesting that
acquisition of helper T cell fate may be differentially influenced
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FIGURE 7 | RBP-Jκ deficiency does not alter CD4+ T cell differentiation
in vitro. CD4+ T cells from control and cRBP-Jκ-KO mice were differentiated
under TH1, TH2, or iTreg inducing condition for 3 days followed by
re-stimulation with plate-bound anti-CD3. Cells were analyzed by flow
cytometry. Supernatants were used for ELISA. (A) Dot plots showing
intra-cellular staining for IFN-γ and IL-4. (B) Percentage and absolute numbers
of IFN-γ or IL-4 positive cells determined by flow cytometry. Numbers in each
quadrant represent percentage of cells n>3. (C) IFN-γ and IL-4 production
under TH1 and TH2 conditions respectively determined by an ELISA. Each data
point represents one animal. (D,G) Dot plots showing intra-cellular staining for
(D) T-bet and N1IC under TH1 conditions and (G) GATA3 and N1IC under TH2
conditions. (E,H) Percentages and absolute numbers of double positive cells
determined by flow cytometry n=5. (F,I) Histograms for T-bet and GATA3
expression under TH1 and TH2 conditions, respectively. Data represent at least
three independent experiments. (J) Flow cytometry plots for CD25+ and
FoxP3+ cells. (K) Percentages and absolute numbers of double positive cells
determined by flow cytometry n=3. Data represent mean±SEM. *p< 0.05,
ns, not significant. Data represent three to five independent experiments.
by canonical and non-canonical Notch signaling. Whether the
absence of RBP-Jκ influenced polarization of CD4+ T cells in vitro
was determined by skewing cells from control or cRBP-Jκ-KO
animals toward TH1 and TH2 cell fates. While the number of cells
secreting IFN-γ was reduced in the CD4+ T cells from cRBP-Jκ-
KO mice (Figures 7A,B), the amount of IFN-γ secreted under TH1
conditions was unaffected (Figure 7C). Levels of T-bet remained
unchanged in the absence of RBP-Jκ in comparison to controls
(Figures 7D–F). Similarly, RBP-Jκ-deficiency did not alter polar-
ization toward TH2. Although, CD4+ T cells from RBP-Jκ-KO
animals had lower amounts of GATA3 (Figures 7G–I) this decrease
did not influence the number of IL-4 positive cells (Figures 7A,B)
or the amount of secreted IL-4 under TH2 conditions in vitro
(Figure 7C). In addition to TH1 and TH2 phenotypes, the absence
of RBP-Jκ did not impair the ability to induce regulatory T cells.
The number of CD25+Foxp3+ cells was significantly increased in
cRBP-Jκ-KO animals (Figures 7J,K). These data show that differ-
entiation of CD4+ T cells in vitro does not require canonical Notch
signaling.
DISCUSSION
Several studies have demonstrated the generation of the active,
intra-cellular domain of Notch in T cells stimulated via the TCR
accompanied by co-stimulation (15, 16). In this report, we address
precisely where Notch exerts influence downstream of the TCR
signaling cascade. We specifically outline the kinetics of Notch
activation in peripheral T cells and suggest that Notch is most
important for regulating signaling events distal to the TCR. We
show that inhibition of Notch activation had no effect on phos-
phorylation of Zap70, a proximal TCR signaling event. However,
GSI treatment effectively abolished the expression of T cell acti-
vation markers – CD25, CD69, IL-2, and IFN-γ, events that occur
several hours following TCR stimulation. In addition, GSI treat-
ment also abolished the expression of c-Myc most prominently at
14–48 h post TCR stimulation. While these data do not exclude a
role of Notch in affecting other early TCR events besides phospho-
rylation of Zap70, they suggest that Notch has a very significant
influence on distal events. Furthermore, our data also reveal a
critical influence of Notch activation on TCR signal strength. We
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show that stimulating T cells with increasing concentrations of
either anti-CD3ε or antigen pulsed APCs, increased the amount
of N1IC in proportion to increasing signal strength. Although, we
did observe basal levels of N1IC expression in CD4+ T cells stimu-
lated with CHO-APCs in the absence of ova-peptide, CHO-APCs
express low levels of Jagged 1 and likely contribute to the basal
expression of N1IC. Most importantly, abrogating Notch activa-
tion either via GSI treatment or conditional deletion significantly
increased the threshold of signaling via the TCR. While Notch has
been implicated in influencing strength of signal in thymocytes
(23), our data demonstrate for the first time a role of Notch as a
regulator of signal strength in peripheral CD4+ T cells. We also
observed a concomitant increase in c-Myc in response to increas-
ing signal. While a similar response has been recently documented
in peripheral T cells (24), our data add to these data by showing
that an increase in c-Myc in response to increasing signal strength
is, in fact, Notch dependent. These data also suggest that Notch
may likely exert control over signal strength via c-Myc. How-
ever, further experimentation is required to investigate the precise
mechanism that underlies Notch dependent regulation of signal
strength.
Many studies have implicated a role of Notch in regulating
peripheral T cell responses using GSIs to inhibit Notch activity (4,
15, 16). However, the use of GSIs obscures the specific contribu-
tion of Notch1 in regulating these processes since GSIs inhibit all
isoforms of the Notch receptor and have multiple substrates, some
of which are important in immune function (17). Thus, GSI treat-
ment may not only inhibit Notch but other type I transmembrane
proteins as well suggesting that attenuation of T cell responses
post GSI treatment may not necessarily be due to Notch1. Here,
we specifically address such concerns by conditionally deleting
Notch1 using the Mx Cre system, which produces “acute” deletion
of Notch1 in peripheral T cells. CD4+ T cells from cN1KO animals
showed a significant reduction in CD25, CD69, IL-2, and IFN-γ
coupled with impaired proliferation that could not be rescued in
the presence of exogenous IL-2. In addition, although CD4+ T
cells from cN1KO animals expressed Notch2 and Notch3, it was
not sufficient to rescue activation or proliferation. Thus, our data
show that activation and proliferation are in fact Notch dependent
processes that specifically require Notch1.
The precise function of Notch signaling in determining TH1
versus TH2 lineage decisions remains controversial partially due
to the disparate methods used to attenuate Notch signaling. Inhi-
bition of Notch signaling via GSIs blocked TH1 cell fate in vitro and
in vivo by preventing Notch mediated up-regulation of T-bet but
did not alter TH2 responses in vitro (4). On the contrary, inhibition
of RBP-Jκ function either by genetic deletion or by using dominant
negative co-activators of RBP-Jκ such as dnMAML (dominant
negative MAML), which mimics a loss-of-Notch function phe-
notype, preserved TH1 responses but dampened TH2 responses
in vivo (18, 21–23, 33). In models of RBP-Jκ deletion, the genera-
tion of N1IC is preserved (Figure 5). This is particularly important
since N1IC has also been documented to interact with other pro-
teins besides RBP-Jκ (3–5). Therefore, we reasoned that since
Notch1 is known to interact with proteins other than RBP-Jκ, N1IC
may be capable of functioning in an RBP-Jκ independent fashion
and such “non-canonical” signaling could serve to reconcile exist-
ing differences about the precise role of Notch in influencing T cell
differentiation. To this end, we generated mice with a conditional
deletion of either Notch1 or RBP-Jκ and determined whether
deleting different components of the Notch pathway produced dis-
tinct phenotypes. Furthermore, we specifically chose to study how
the absence of Notch signaling affects T cell differentiation in vitro
to delineate a cell-intrinsic role of Notch in controlling effector T
cell responses in contrast to previously used in vivo approaches,
which cannot distinguish between extrinsic and intrinsic effects.
We show that conditionally deleting Notch1 attenuates TH1
responses in vitro as observed by a significant decrease in the per-
centage of cells secreting IFN-γ, the amount of secreted IFN-γ
and the amount of T-bet expressed suggesting that Notch1 is in
fact required for TH1 decisions. Another study has shown that
deleting Notch1 under the control of a CD4 Cre promoter does
not dampen TH1 responses in vitro. We suggest that the differences
between this study and ours may most likely be due to the different
approaches used to delete Notch since deletion under the control
of the CD4 Cre promoter, deletes Notch during thymic devel-
opment. Apart from TH1, we also show that deletion of Notch1
impaired the ability to generate induced regulatory T cells. Inhi-
bition of Notch via GSIs has also been shown to decrease iTreg
populations, suggestive of a requirement for Notch1 in regulat-
ing these responses. Although, we observed a decrease in both
TH1 and iTreg populations in the absence of Notch1, we did not
see any decrease in TH2 responses in vitro. We have shown previ-
ously that inhibition of Notch via GSIs under TH2 conditions does
not alter IL-4 production (4). Corroborating these observations,
another study showed that genetic deletion of presenilin, a com-
ponent of the γ-secretase complex, did not alter TH2 responses
in vitro (41). Our TH2 data concur with these reports suggesting
that Notch1 is dispensable for intrinsic acquisition of a TH2 cell
fate in vitro.
To determine the contribution of RBP-Jκ dependent, canoni-
cal Notch signaling in regulating activation and differentiation of
peripheral CD4+ T cells, we conditionally deleted RBP-Jκ once
again under the control of the Mx promoter facilitating acute
deletion. CD4+ T cells from cRBP-Jκ-KO animals expressed N1IC
upon TCR stimulation. Strikingly, contrary to CD4+ T cells from
cN1KO animals, CD4+ T cells from cRBP-Jκ-KO animals were
not deficient in activation or proliferation and expressed all acti-
vation markers at identical levels to CD4+ T cells from control
mice suggesting an RBP-Jκ independent role of Notch signal-
ing in regulating these processes. We confirmed this by showing
that only after intra-cellular Notch is inhibited in CD4+ T cells
lacking RBP-Jκ, activation and proliferation can be decreased.
Additionally, an NS-GSI could “rescue” activation and prolifer-
ation in the absence of RBP-Jκ. The NS-GSI only partially res-
cued IFN-γ. A possible explanation for this observation is that
Notch may regulate IFN-γ production via an intermediary mol-
ecule, which is a GSI target and is hence not spared by the
NS-GSI. While these data suggest only a partial requirement of
N1IC for IFN-γ production, determining the precise molecular
players that interact with Notch to regulate IFN-γ, requires fur-
ther experimentation. Our data concur with previously reported
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observations that showed no overt effect of RBP-Jκ deletion
on T cell activation or proliferation (23, 41–43). However, our
study is the first to suggest that this is due to non-canonical
Notch signaling as N1IC could compensate for the absence of
RBP-Jκ.
The mechanism by which non-canonical Notch signaling regu-
lates activation, proliferation, and differentiation requires further
investigation. Our data along with that of others suggest NF-κB
to be the most likely candidate (3, 15, 36, 37). Thus, to deter-
mine if some of the effects of non-canonical Notch signaling
require NF-κB, we inhibited NF-κB in the absence of RBP-Jκ.
Inhibition of NF-κB did not alter the levels of intra-cellular
Notch1 but still decreased the expression of CD25, CD69, IL-
2, and IFN-γ in CD4+ cells from cRBP-Jκ-KO animals NF-κB
inhibition also attenuated proliferation in the absence of RBP-
Jκ. Furthermore, attenuation of NF-κB in the absence of RBP-
Jκ attenuated a TH1 response in vitro since DHMEQ treatment
reduced the expression of IFN-γ and T-bet in cells lacking RBP-
Jκ (Figures S6C,D in Supplementary Material), suggesting that
RBP-Jκ independent but Notch1 dependent regulation of these
responses may require NF-κB. Additionally, inhibiting NF-κB sig-
nificantly affected T cell activation only at a distal time point
of 48 h and abolished the expression of c-Myc suggesting that
Notch may require NF-κB to control these processes (Figure S5
in Supplementary Material). However, deciphering the precise
mechanism of such NF-κB mediated non-canonical Notch sig-
naling is an ongoing area of investigation that requires further
experimentation.
To extend the contribution of non-canonical Notch signaling
to helper T cell differentiation, we validated TH1, TH2, and iTreg
responses in vitro in the absence of RBP-Jκ. In stark contrast to
CD4+ T cells from cN1KO animals which showed a markedly
dampened TH1 response, CD4+ T cells from cRBP-Jκ-KO mice
secreted IFN-γ and expressed T-bet just as efficiently as controls.
These data once again showcase RBP-Jκ independent, but Notch1
dependent regulation of effector T cell responses in vitro. A recent
study has also suggested such RBP-Jκ independent Notch signaling
in regulating TH1 responses in vivo by showing that CD4+ T cells
lacking RBP-Jκ could mount a protective response to Leishmania
major but those lacking both the Notch1 and Notch2 receptors
could not (34). In addition to TH1, we observed an increase in the
number of CD25+FoxP3+ double positive cells in the absence of
RBP-Jκ suggesting that induction of regulatory T cells may also
rely on non-canonical Notch signaling. This observation was in
contrast to a significant decrease of the same subset seen in the
absence of Notch1 (Figures 4J,K). These differences can be recon-
ciled by the fact that cRBP-Jκ-KO mice continue to express elevated
levels of N1IC. Since N1IC is required for T-reg lineage determi-
nation, an increase in N1IC expression in the absence of RBP-Jk,
could be responsible for a significant increase in the regulatory
T cell population. Additionally, since RBP-Jκ is a transcriptional
repressor, deletion of RBP-Jκ could de-repress FoxP3, resulting in
an increase in the number of CD25+FoxP3+ T-regs. Finally, we
did not observe an effect of RBP-Jκ deficiency on the secretion
of TH2 cytokines in vitro. Our data do not support an intrin-
sic role for Notch1 signaling in TH2 responses. However, since
Notch1 acts upstream of IL-4 and Notch1 has been shown to reg-
ulate IL-4 secretion by NKT cells, we suggest that Notch1 regulates
TH2 responses extrinsically and may instead regulate in vivo IL-4
production.
In conclusion, our in vitro approach resolves discrepancies
about the role of Notch signaling in CD4+ T cell function by
showing that Notch1 regulates T cell activation, proliferation, and
differentiation in a cell-intrinsic fashion. Importantly, our data
demonstrate for the first time that RBP-Jκ independent, non-
canonical Notch signaling regulates activation, proliferation, and
acquisition of TH1 and iTreg fates in vitro. Such non-canonical
Notch signaling most likely involves NF-κB. Evidence of non-
canonical Notch signaling has been observed during axon guid-
ance as well as dorsal closure during embryonic development in
Drosophila (44, 45). In addition, a cytosolic function of Notch
is required for survival of neural stem cells (46). Non-canonical
Notch signaling has recently been shown to influence the IL-
6/JAK/STAT pathway in breast tumors in a fashion that requires
NF-κB (47). Additionally, mammary tumor development has been
shown to occur independently of RBP-Jκ. Further studies are
required to delineate the precise molecular mechanisms under-
lying non-canonical Notch signaling however our data as well as
others support a role for NF-κB in mediating non-canonical Notch
signaling.
MATERIALS AND METHODS
ANIMALS
All animals were housed in animal facilities as per the guidelines
approved by the Institutional Animal Care and Use Committee
at the University of Massachusetts-Amherst. C57BL/6J mice and
BALB/c-Tg (DO11.10)10Loh/J were purchased from the Jackson
Laboratory (Bar Harbor,ME,USA). cN1KO and cRBP-Jκ-KO mice
were generated by breeding Notch1fl/fl (Notch1tm2Rko/GridJ) or Rbp-
jκfl/fl (Rbpjtm1Hon) mice to mx1Cre± [B6.Cg-Tg(mx1cre)1Cgn/J]
mice from the Jackson Laboratory (Bar Harbor, ME, USA). All
mice – Notch1fl/fl×Mx Cre± mice (cN1KO), Notch1fl/fl×Mx
Cre−/− (Control), RBP-Jκfl/fl×Mx Cre± (cRBP-Jκ-KO) and
RBP-Jκfl/fl×Mx Cre−/− (Control) were injected with 12–
15µg/g body weight of Poly I:Poly C (GE Healthcare, Imgenex)
every other day for 5 days. Animals were sacrificed after a 3-
week resting period. Mice aged 7–12 weeks were used for all
experiments.
T CELL ISOLATION AND IN VITRO ASSAYS
CD4+ T cells were isolated by magnetic separation using anti-
CD4 magnetic particles (BD Pharmingen). Cells were activated
in vitro by plating 3× 106 cells/ml on each well of a 12-well
plate pre-coated with anti-CD3ε and anti-CD28 purified from
145-2c11 and 37N hybridoma cell lines respectively and cross-
linked with anti-Hamster IgG (Sigma). Cells were activated in
a half and half mixture of RPMI and DMEM (Lonza) supple-
mented with 10% Fetal Bovine Serum (GIBCO), l-Glutamine,
Na-pyruvate, and Penicillin/Streptomycin (Lonza). The following
conditions were used for polarization. TH1: 10µg/ml anti-IL-4
and 1 ng/ml recombinant mouse IL-12 (BD Pharmingen). TH2:
10µg/ml anti-IFN-γ and 1 ng/ml of recombinant mouse IL-4
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(BD Pharmingen). iTreg: CD4+CD25− cells were enriched from
bulk splenocytes using the mouse CD4 T-lymphocyte enrichment
set with 2.5µg biotin conjugated anti-CD25 (BD Pharmingen).
Cells were activated in the presence of 2 ng/ml of recombinant
human TGFβ1 (R&D systems). Cytokines from supernatants were
determined using a standard ELISA assay (BD Pharmingen). For
thymidine uptake assays, 3× 105 cells/ml were activated in 96-well
plates pre-coated with anti-CD3ε and anti-CD28 in the presence
or absence of 20 ng/ml recombinant mouse IL-2 (BD Pharmin-
gen). Cells were pulsed with 3H-thymidine (Perkin Elmer) at a
final concentration of 1µci/rxn in the final 16 h of activation.
Cells were harvested on a mash harvester into scintillation vials.
Counts per minute were obtained on a scintillation counter (Beck-
man). For CFSE assays, CD4+ T cells were labeled with 1µM CFSE
using the manufacturer’s protocol (Molecular Probes). Cells were
stimulated for 48 h before analysis by flow cytometry. For drug
treatments, CD4+ T cells were pretreated with 50µM of the GSI
z-IL-CHO, 5µM NS-GSI JLK-6 (Tocris Bioscience), or 2µM of
DHMEQ at 37°C for 30 min before activation.
STRENGTH OF SIGNAL ASSAYS
CD4+ T cells were isolated from the spleens of C57BL/6J as
described and stimulated with the indicated concentrations of
anti-CD3ε and 1µg/ml of anti-CD28 (BD Pharmingen) for 48 h.
Cells were analyzed by flow cytometry and IL-2 was detected in
the supernatants by an ELISA. For co-culture experiments, empty
vector Chinese Hamster Ovary – Antigen-presenting cells (CHO-
APCs) were fixed by treating with Mitomycin C (Sigma) 37°C for
45 min 6× 105 cells/ml of CHO-APCs were pulsed with the indi-
cated concentrations of ova-peptide 323–339 (Genscript). CD4+
T cells were isolated from spleens of BALB/c-Tg(DO11.10)10Loh/J
and mixed with peptide pulsed APCs at 2.5× 106 cells/ml in each
well of a 12-well plate. Cells were harvested after 48 h and ana-
lyzed by flow cytometry after gating on CD4+ T cells expressing
the DO.11.10-TCR. Supernatants were used for detection of IL-2
by an ELISA.
FLOW CYTOMETRY
Surface staining was performed in PBS with 1% BSA using
the indicated antibodies – CD25-APC, CD69-FITC (eBio-
science), CD4-PerCP (BD Pharmingen), Anti-mouse DO.11.10-
TCR Biotin (Invitrogen), Streptavidin PerCP (BD Pharmingen).
Intra-cellular staining was performed for detection of intra-
cellular Notch1, T-bet, GATA3, and FoxP3 using the FoxP3 stain-
ing buffer set (eBioscience) and the following antibodies: anti-
Human/Mouse Notch1-PE, anti-Human/Mouse T-bet PE-Cy7,
anti-Human/Mouse GATA3 eFluor 660, anti-Mouse/Rat FoxP3
Alexa 488 (eBioscience). For detection of intra-cellular cytokines,
cells were harvested at indicated time points and re-stimulated
with plate-bound anti-CD3ε in the presence of Golgi Plug (IFN-
γ) or Golgi Stop (IL-4) (BD Pharmingen) for 5 h. Intra-cellular
cytokine staining was performed using the BD Cytofix/CytoPerm
plus kit and cytokines detected using anti-Mouse IFN-γ FITC
and anti-Mouse IL-4 PE (BD Pharmingen). Flow cytometry
data was acquired on a FACS LSR II (BD) and analyzed using
FlowJo software (Trestar) after gating on CD4+ T cells or as
indicated.
WESTERN BLOT
Whole cell lysates were made in RIPA buffer (150 mM NaCl,
1% IgeCal-CA 360, 0.1% SDS, 50 mM Tris, pH-8.0, 0.5%
Sodium deoxycholate). Cytoplasmic and nuclear proteins were
extracted as per the manufacturer’s instructions (Thermo Scien-
tific). Lysates were resolved on an SDS-PAGE gel. Protein was
a transferred on a nitro-cellulose membrane and blocked in
Blotto (5% milk powder, 0.2% Tween-20 in PBS). Membranes
were probed over-night with primary antibody. Membranes
were washed and incubated with horse-radish peroxidase (HRP)
labeled secondary antibody. Membranes were developed using
ECL reagents (Amersham). Primary Antibodies: anti-RBPSUH,
anti-phospho Zap 70 (Y319), anti-Zap70, anti-HDAC (Cell signal-
ing), anti-c-Rel (Santa Cruz Biotechnology) anti-Actin (Sigma),
anti-c-Myc (9E10) was obtained from Dr. Dominique Alfan-
dari. Secondary Antibody: anti-Rabbit-HRP, anti-Mouse-HRP
(Amersham).
STATISTICAL ANALYSIS
All data are represented as mean± SEM. Statistical Analysis was
performed using the GraphPad Prism 5 software. p Values were
calculated using an unpaired two-tailed Student’s t -test.
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